Hepatic arterial infusion chemotherapy (HAIC) combined with Regorafenib and PD-1 inhibitors versus Regorafenib combined with PD-1 inhibitors for second-line treatment Hepatocellular carcinoma (HCC)

作者全名:"You, N.; Peng, X.; Li, J.; Wang, L.; Wu, K.; Zheng, L.; Li, D.; Chen, Z.; Zhang, H.; Huang, P.; Wang, Y.; Liao, R.; Li, Q.; Guo, P.; Wang, W."

作者地址:"[You, N.; Peng, X.; Li, J.; Wang, L.; Wu, K.; Zheng, L.] Army Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 2, Chongqing, Peoples R China; [Li, D.; Wang, Y.] Chongqing Univ, Dept Hepatobiliary, Canc Hosp, Pancreat Tumor Ctr, Chongqing, Peoples R China; [Chen, Z.; Zhang, H.] Third Mil Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Army Mil Univ, Chongqing, Peoples R China; [Huang, P.; Liao, R.] Chongqing Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Chongqing, Peoples R China; [Li, Q.] Chongqing Univ, Dept Intervent Radiol, Canc Hosp, Chongqing, Peoples R China; [Guo, P.] Chongqing Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 3, Chongqing, Peoples R China; [Wang, W.] Peoples Hosp Tongliang Dist Chongqing city, Dept Hepatobiliary Surg, Chongqing, Peoples R China"

通信作者: 

来源:ANNALS OF ONCOLOGY

ESI学科分类:CLINICAL MEDICINE

WOS号:WOS:001087480201308

JCR分区:Q1

影响因子:56.7

年份:2023

卷号:34

期号: 

开始页:S605

结束页:S605

文献类型:Meeting Abstract

关键词: 

摘要: 

基金机构: 

基金资助正文: